Summary
Thermo Fisher Scientific Inc. (TMO) filed an 8-K on June 2, 2005, detailing significant financing activities. The company issued and sold $250 million of 5% Senior Notes due 2015. The proceeds from these notes, along with cash on hand, were used to repay $250 million of the outstanding balance under the company's 364-Day Credit Agreement, which was originally put in place to finance the acquisition of SPX Corporation's Kendro Laboratory Products division. This move indicates a refinancing of acquisition-related debt, shifting towards longer-term senior notes. In addition to the senior notes, Thermo Fisher also entered into a Money Market Loan Program with JPMorgan Chase Bank, N.A., securing an uncommitted line of credit of up to $250 million. On May 27, 2005, the company immediately drew $250 million under this program through short-term loans, also used to repay a portion of the outstanding Bridge Facility. These transactions demonstrate active management of the company's debt structure and liquidity, aimed at funding strategic acquisitions and managing short-term credit needs.
Key Highlights
- 1Issued and sold $250 million in aggregate principal amount of 5% Senior Notes due 2015.
- 2Used proceeds from Senior Notes to repay $250 million of outstanding debt under a 364-Day Credit Agreement related to the Kendro acquisition.
- 3Entered into a Money Market Loan Program providing an uncommitted line of credit up to $250 million.
- 4Borrowed $250 million under the Money Market Loan Program to further repay the 364-Day Credit Agreement (Bridge Facility).
- 5The Senior Notes are senior unsecured obligations, ranking equally with other unsecured and unsubordinated debt.
- 6The Indenture for the Senior Notes includes limited affirmative and negative covenants restricting debt, sale-leasebacks, and asset sales.
- 7A Registration Rights Agreement was executed, requiring TMO to file registration statements for an exchange offer of the Senior Notes within specific timeframes or face potential additional interest payments.